Compare RAPP & ALGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RAPP | ALGT |
|---|---|---|
| Founded | 2022 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Air Freight/Delivery Services |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 2024 | 2006 |
| Metric | RAPP | ALGT |
|---|---|---|
| Price | $39.32 | $92.14 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 10 |
| Target Price | $48.50 | ★ $97.30 |
| AVG Volume (30 Days) | 290.1K | ★ 606.7K |
| Earning Date | 05-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 24.34 | ★ 81.62 |
| EPS | N/A | ★ 2.30 |
| Revenue | N/A | ★ $2,606,579,000.00 |
| Revenue This Year | N/A | $9.42 |
| Revenue Next Year | N/A | $6.52 |
| P/E Ratio | ★ N/A | $39.45 |
| Revenue Growth | N/A | ★ 3.74 |
| 52 Week Low | $8.20 | $43.03 |
| 52 Week High | $42.27 | $118.00 |
| Indicator | RAPP | ALGT |
|---|---|---|
| Relative Strength Index (RSI) | 61.52 | 62.39 |
| Support Level | $25.48 | $83.67 |
| Resistance Level | $41.33 | $94.77 |
| Average True Range (ATR) | 2.08 | 4.57 |
| MACD | 0.18 | 2.00 |
| Stochastic Oscillator | 84.38 | 91.08 |
Rapport Therapeutics Inc is a clinical-stage biotechnology company dedicated to the discovery and development of small-molecule precision medicines for patients with neurological or psychiatric disorders. The company's portfolio of programs from its RAP technology platform includes RAP-219, an investigational small molecule being developed as a therapy for focal onset seizures, primary generalized tonic-clonic seizures, and bipolar mania. Additionally, it has two discovery-stage nicotinic acetylcholine receptor (nAChR) programs stemming from its RAP technology platform: one being developed for the treatment of chronic pain, and the second, being developed for the treatment of hearing disorders. Geographically, the company operates in the United States.
Allegiant Travel Co is a leisure travel company focused on providing travel and leisure services and products to residents of underserved cities in the United States. It operates a low-cost, low utilization passenger airline marketed to leisure travelers in underserved cities, allowing it to sell air transportation both on a stand-alone basis and bundled with the sale of air-related and third-party services and products. In addition, it provides air transportation under fixed-fee flight arrangements. In connection with its leisure travel focus, the company has opened Sunseeker Resort Charlotte Harbor, equipped with several guestrooms and food and beverage outlets. The company's operating segments are the Airline, which generates the maximum revenue, and Sunseeker Resort.